BRIEF-Onconetix Sets Stage For Potential Business Combination With Ocuvex Therapeutics

Reuters
08 Apr
BRIEF-Onconetix Sets Stage For Potential Business Combination With Ocuvex <a href="https://laohu8.com/S/LENZ">Therapeutics</a>

April 8 (Reuters) - Onconetix and Ocuvex Therapeutics:

  • ONCONETIX SIGNS LETTER OF INTENT FOR POTENTIAL BUSINESS COMBINATION WITH OCUVEX THERAPEUTICS, INC.

  • ONCONETIX- POST CLOSE, PRE-CLOSING OCUVEX EQUITY HOLDERS WILL OWN ABOUT 90% OF EQUITY INTERESTS IN ONCONETIX

  • ONCONETIX INC - ONCONETIX AND OCUVEX WILL CONTINUE NEGOTIATIONS TO ENTER INTO A DEFINITIVE AGREEMENT

Source text: ID:nGNX4KTqqm

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10